Transgenomic, Inc. (TBIO) - 500 Beiträge pro Seite
eröffnet am 03.11.06 17:19:04 von
neuester Beitrag 11.12.06 19:08:49 von
neuester Beitrag 11.12.06 19:08:49 von
Beiträge: 10
ID: 1.092.129
ID: 1.092.129
Aufrufe heute: 0
Gesamt: 831
Gesamt: 831
Aktive User: 0
ISIN: US74019L6020 · WKN: A3ETCE · Symbol: PRPO
5,9200
USD
-1,66 %
-0,1000 USD
Letzter Kurs 17:27:07 Nasdaq
Werte aus der Branche Biotechnologie
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 0,6500 | +536,63 | |
| 7,0500 | +40,44 | |
| 4,7450 | +35,57 | |
| 4,2000 | +22,09 | |
| 0,7400 | +18,55 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 1,6100 | -15,26 | |
| 6,0700 | -16,62 | |
| 0,7152 | -16,84 | |
| 0,6050 | -18,24 | |
| 27,29 | -23,15 |
Feedback
Profile:Transgenomic, Inc. engages in the development, assembling, manufacture, and marketing of products to the medical research, clinical, and pharmaceutical markets for use in genetic variation analysis. The company also provides analytical services for use in genetic variation analysis. Its primary offering, WAVE System, is applicable to genetic variation detection in molecular genetic research and molecular diagnostics. The company also manufactures bioconsumable products, including separation columns, liquid reagents, and enzymes. In addition, it offers consumable products comprising SURVEYOR Nuclease and various HPLC separation columns for use in multiple and independent platforms. Transgenomic also provides various genetic laboratory services, including genomic biomarker analysis services to pharmaceutical and biopharmaceutical companies to support preclinical and clinical development of targeted therapeutics; and molecular-based testing for hematology, oncology, and inherited diseases for physicians and third-party laboratories through contract research labs. The company offers its products and services to biomedical researchers, medical institutions, and diagnostic and pharmaceutical companies through direct sales staff, dealers, and distributors worldwide. Transgenomic was co-founded by Collin J. D’Silva. The company was incorporated in 1997 and is based in Omaha, Nebraska.
http://www.transgenomic.com/
http://www.transgenomic.com/
Turnaround beginnt
Webcast Alert: Transgenomic Inc. Announces Third Quarter 2006 Earnings Release Conference Call Webcast
Wednesday November 8, 4:00 pm ET
OMAHA, Neb., Nov. 8 /PRNewswire-FirstCall/ -- Transgenomic Inc. (Nasdaq: TBIO - News) announces the following Webcast:
What: Transgenomic Inc. Third Quarter 2006 Earnings Release Conference
Call
When: Tuesday, November 14, 2006 @ 5:00 p.m. Eastern
Where: http://www.transgenomic.com/events.asp?id=6
How: Live over the Internet -- Simply log on to the web at the
address above.
Contact: Investor Relations, 402-452-5400
To access the call via telephone, call 877-707-9628 or 785-832-1523. A replay of the call will be available via telephone until 11:59 pm ET on Tuesday, November 28, 2006. To access, dial 800-839-4014 or 402-220-2983.
About Transgenomic
Transgenomic is a global biotechnology company that provides unique products and services for automated high sensitivity genetic variation and mutation analysis. Their offerings include systems, products, discovery and laboratory testing services to the academic and medical research, clinical laboratory and pharmaceutical markets in the fields of pharmacogenomics and personalized medicine. Specific offerings include Wave(TM) DHPLC systems, reagents, consumables and assay kits, Hanabi automated cytogenetics systems, and Transgenomic Discovery and CLIA Lab Services. To date there have been over 1,200 Wave systems installed in over 600 customer sites in over 35 countries and approximately 1,500 publications utilizing Transgenomic products or services. Transgenomic Discovery and Lab Services utilize their technology and expertise to provide a menu of mutation scanning tests for over 700 cancer-associated genes and more than 60 validated diagnostic tests to meet the needs of pharmaceutical and biotech companies, research and clinical laboratories, physicians and patients. For more information about the innovative systems, products and services offered by Transgenomic, please visit: www.transgenomic.com.
--------------------------------------------------------------------------------
Source: Transgenomic Inc.
Wednesday November 8, 4:00 pm ET
OMAHA, Neb., Nov. 8 /PRNewswire-FirstCall/ -- Transgenomic Inc. (Nasdaq: TBIO - News) announces the following Webcast:
What: Transgenomic Inc. Third Quarter 2006 Earnings Release Conference
Call
When: Tuesday, November 14, 2006 @ 5:00 p.m. Eastern
Where: http://www.transgenomic.com/events.asp?id=6
How: Live over the Internet -- Simply log on to the web at the
address above.
Contact: Investor Relations, 402-452-5400
To access the call via telephone, call 877-707-9628 or 785-832-1523. A replay of the call will be available via telephone until 11:59 pm ET on Tuesday, November 28, 2006. To access, dial 800-839-4014 or 402-220-2983.
About Transgenomic
Transgenomic is a global biotechnology company that provides unique products and services for automated high sensitivity genetic variation and mutation analysis. Their offerings include systems, products, discovery and laboratory testing services to the academic and medical research, clinical laboratory and pharmaceutical markets in the fields of pharmacogenomics and personalized medicine. Specific offerings include Wave(TM) DHPLC systems, reagents, consumables and assay kits, Hanabi automated cytogenetics systems, and Transgenomic Discovery and CLIA Lab Services. To date there have been over 1,200 Wave systems installed in over 600 customer sites in over 35 countries and approximately 1,500 publications utilizing Transgenomic products or services. Transgenomic Discovery and Lab Services utilize their technology and expertise to provide a menu of mutation scanning tests for over 700 cancer-associated genes and more than 60 validated diagnostic tests to meet the needs of pharmaceutical and biotech companies, research and clinical laboratories, physicians and patients. For more information about the innovative systems, products and services offered by Transgenomic, please visit: www.transgenomic.com.
--------------------------------------------------------------------------------
Source: Transgenomic Inc.
mhhh...
irgendwanmn knallt TBIO durch die decke!
irgendwanmn knallt TBIO durch die decke!
langsam
Trading Spotlight
gestern die ganze zeit fettes Bid!
sieht gut aus..könnte bald explodieren
bitte einsteigen
in der spitze fast bei 0,90$!!!
DurchsuchenBeitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Investoren beobachten auch:
| Wertpapier | Perf. % |
|---|---|
| -1,19 | |
| -0,88 | |
| -5,17 | |
| -1,05 | |
| -2,78 | |
| -2,16 | |
| +0,64 | |
| +2,15 | |
| -1,09 | |
| -0,36 |
Meistdiskutiert
| Wertpapier | Beiträge | |
|---|---|---|
| 200 | ||
| 199 | ||
| 96 | ||
| 84 | ||
| 68 | ||
| 61 | ||
| 44 | ||
| 24 | ||
| 24 | ||
| 23 |
